COMBINATION, SET AND METHOD OF REDUCING THE INTRA-GULF PRESSURE

摘要

The invention is directed to a combination or kit containing a prostaglandin analog and an adenosine A receptor agonist, and to a method for reducing intraocular pressure (IOP) in a subject using such a combination or kit. The invention, in particular, is directed to a combination of latanoprost, marketed under the brand name Xalantan, and compound A.